{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:40:25Z","timestamp":1791218425402,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.psyneuen.2014.06.010","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T20:16:04Z","timestamp":1403036164000},"page":"77-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways"],"prefix":"10.1016","volume":"48","author":[{"given":"Jiamei","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagesh","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2014.06.010_bib0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/13543784.17.5.795","article-title":"Betahistine: what's new on the agenda?","volume":"17","author":"Barak","year":"2008","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0015","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/ijo.2008.135","article-title":"Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial","volume":"32","author":"Barak","year":"2008","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0020","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1073\/pnas.95.25.15043","article-title":"The neuropeptide Y\/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice","volume":"95","author":"Broberger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"63","author":"Brown","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0030","series-title":"Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"Center for Drug Evaluation and Research FDA","year":"2005"},{"issue":"Suppl. 2","key":"10.1016\/j.psyneuen.2014.06.010_bib0035","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","article-title":"From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics","volume":"25","author":"Correll","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ecl.2013.05.006","article-title":"Effects of antipsychotic medications on appetite, weight, and insulin resistance","volume":"42","author":"Deng","year":"2013","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0045","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1177\/0269881112449396","article-title":"Reducing olanzapine-induced weight gain side-effect by betahistine: a study in the rat model","volume":"26","author":"Deng","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0260","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.pnpbp.2007.02.009","article-title":"Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats","volume":"31","author":"Deng","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2009.11.009","article-title":"The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?","volume":"34","author":"Deng","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0055","first-page":"6","article-title":"Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation","author":"Fern\u00f8","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/phrs.2000.0795","article-title":"Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents","volume":"43","author":"Fossati","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.psyneuen.2008.01.018","article-title":"Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression","volume":"33","author":"Han","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0070","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40263-013-0062-1","article-title":"The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain","volume":"27","author":"He","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psyneuen.2014.01.018","article-title":"Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats","volume":"42","author":"He","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0006-3223(98)00044-4","article-title":"Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats","volume":"45","author":"Itoh","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0085","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/00002018-200629110-00004","article-title":"Betahistine: a retrospective synopsis of safety data","volume":"29","author":"Jeck-Thole","year":"2006","journal-title":"Drug Saf."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000090982","article-title":"Histaminergic neurons are involved in the orexigenic effect of orexin-A","volume":"82","author":"Jorgensen","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0100","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Suppl. 6","key":"10.1016\/j.psyneuen.2014.06.010_bib0105","first-page":"5","article-title":"Neuro-hormonal control of food intake: basic mechanisms and clinical implications","volume":"56","author":"Konturek","year":"2005","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0110","first-page":"429","article-title":"Betahistine in the treatment of M\u00e9ni\u00e8re's disease","volume":"3","author":"Lacour","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.molmed.2008.09.007","article-title":"AMPK: a metabolic gauge regulating whole-body energy homeostasis","volume":"14","author":"Lage","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pbb.2010.09.003","article-title":"Brain serotonin system in the coordination of food intake and body weight","volume":"97","author":"Lam","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cmet.2008.03.006","article-title":"Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin","volume":"7","author":"Lopez","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0135","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nm.2207","article-title":"Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance","volume":"16","author":"Lopez","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0140","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.2337\/db10-0449","article-title":"Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance","volume":"59","author":"Martins","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/00023210-200721090-00002","article-title":"Neurogenic actions of atypical antipsychotic drugs and therapeutic implications","volume":"21","author":"Newton","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajp.2012.05.005","article-title":"Are there different neural mechanisms responsible for three stages of weight gain development in anti-psychotic therapy: temporally based hypothesis","volume":"5","author":"Pai","year":"2012","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0160","series-title":"The Rat Brain in Sterotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0165","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00213-012-2935-2","article-title":"Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine\u2013betahistine combination","volume":"226","author":"Poyurovsky","year":"2013","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2007","journal-title":"FASEB J."},{"issue":"Suppl. 1","key":"10.1016\/j.psyneuen.2014.06.010_bib0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2009.05916.x","article-title":"AMPK in the brain: its roles in energy balance and neuroprotection","volume":"109","author":"Ronnett","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neubiorev.2014.03.009","article-title":"Modulation of behavior by the histaminergic system: lessons from HR- and HR-deficient mice","volume":"42","author":"Schneider","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0190","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0195","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-011-9663-8","article-title":"A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats","volume":"31","author":"Sejima","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"issue":"Suppl. 1","key":"10.1016\/j.psyneuen.2014.06.010_bib0200","first-page":"1","article-title":"The role of central neuropeptides in weight gain caused by olanzapine","volume":"28","author":"Sezlev","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0205","first-page":"91","article-title":"Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects","volume":"17","author":"Skrede","year":"2014","journal-title":"Int. J. Neuropharmacol."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0210","first-page":"701","article-title":"Betahistine inhibits food intake in rats","volume":"53","author":"Szelag","year":"2001","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.mp.4001009","article-title":"Significant dissociation of brain and plasma kinetics with antipsychotics","volume":"7","author":"Tauscher","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/YPG.0b013e3283458a51","article-title":"Association between the ROBO1 gene and body mass index in patients using antipsychotics","volume":"21","author":"Vehof","year":"2011","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0225","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","article-title":"Dosage response of metabolic dysfunction to olanzapine treatment in female Sprague Dawley rats","volume":"217","author":"Weston-Green","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0230","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","article-title":"Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats","volume":"217","author":"Weston-Green","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0235","doi-asserted-by":"crossref","first-page":"e33548","DOI":"10.1371\/journal.pone.0033548","article-title":"Alterations to melanocortinergic GABAergic and cannabinoid neurotransmission associated with olanzapine","volume":"7","author":"Weston-Green","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0240","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuron.2008.09.033","article-title":"5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis","volume":"60","author":"Xu","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0245","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.peptides.2005.02.028","article-title":"The neuronal histamine H1 and pro-opiomelanocortin\u2013melanocortin 4 receptors: independent regulation of food intake and energy expenditure","volume":"27","author":"Yoshimatsu","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0250","series-title":"Brown Adipose Tissue Thermogenesis is Time-Dependently Downregulated by Olanzapine in Rats","author":"Zhang","year":"2013"},{"key":"10.1016\/j.psyneuen.2014.06.010_bib0255","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S1461145713001697","article-title":"Hypothalamic ghrelin signalling mediates olanzapine induced hyperphagia and weight gain in female rats","volume":"17","author":"Zhang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453014002170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453014002170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:46:45Z","timestamp":1759682805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453014002170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":52,"alternative-id":["S0306453014002170"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2014.06.010","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2014.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}